GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Deinove SA (XPAR:ALDEI) » Definitions » Asset Turnover

Deinove (XPAR:ALDEI) Asset Turnover : 0.02 (As of Jun. 2022)


View and export this data going back to 2010. Start your Free Trial

What is Deinove Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Deinove's Revenue for the six months ended in Jun. 2022 was €0.12 Mil. Deinove's Total Assets for the quarter that ended in Jun. 2022 was €7.69 Mil. Therefore, Deinove's Asset Turnover for the quarter that ended in Jun. 2022 was 0.02.

Asset Turnover is linked to ROE % through Du Pont Formula. Deinove's annualized ROE % for the quarter that ended in Jun. 2022 was 49.94%. It is also linked to ROA % through Du Pont Formula. Deinove's annualized ROA % for the quarter that ended in Jun. 2022 was -92.51%.


Deinove Asset Turnover Historical Data

The historical data trend for Deinove's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deinove Asset Turnover Chart

Deinove Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 - 0.01 0.03 0.04

Deinove Semi-Annual Data
Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.03 0.01 0.02

Competitive Comparison of Deinove's Asset Turnover

For the Biotechnology subindustry, Deinove's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deinove's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Deinove's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Deinove's Asset Turnover falls into.



Deinove Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Deinove's Asset Turnover for the fiscal year that ended in Dec. 2021 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2021 )/( (Total Assets (A: Dec. 2020 )+Total Assets (A: Dec. 2021 ))/ count )
=0.367/( (9.408+9.377)/ 2 )
=0.367/9.3925
=0.04

Deinove's Asset Turnover for the quarter that ended in Jun. 2022 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2022 )/( (Total Assets (Q: Dec. 2021 )+Total Assets (Q: Jun. 2022 ))/ count )
=0.124/( (9.377+6.011)/ 2 )
=0.124/7.694
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Deinove  (XPAR:ALDEI) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Deinove's annulized ROE % for the quarter that ended in Jun. 2022 is

ROE %**(Q: Jun. 2022 )
=Net Income/Total Stockholders Equity
=-7.118/-14.253
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-7.118 / 0.248)*(0.248 / 7.694)*(7.694/ -14.253)
=Net Margin %*Asset Turnover*Equity Multiplier
=-2870.16 %*0.0322*-0.5398
=ROA %*Equity Multiplier
=-92.51 %*-0.5398
=49.94 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2022) net income data. The Revenue data used here is two times the semi-annual (Jun. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Deinove's annulized ROA % for the quarter that ended in Jun. 2022 is

ROA %(Q: Jun. 2022 )
=Net Income/Total Assets
=-7.118/7.694
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-7.118 / 0.248)*(0.248 / 7.694)
=Net Margin %*Asset Turnover
=-2870.16 %*0.0322
=-92.51 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2022) net income data. The Revenue data used here is two times the semi-annual (Jun. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Deinove Asset Turnover Related Terms

Thank you for viewing the detailed overview of Deinove's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Deinove (XPAR:ALDEI) Business Description

Traded in Other Exchanges
N/A
Address
1682 rue de la Valsiere, Cap Sigma, ZAC Euromedecine II, Grabels, FRA, 34790
Deinove SA is a biotechnology company engaged in the development of technologies and molecules for the health, nutrition and cosmetics industries. It is developing in two areas of activity, New-generation anti-infective ANTIBIOTICS which involves the search for novel anti-infective molecules and the development of new generations of drugs capable of responding to the challenges of antibiotic resistance; and BIOACTIVES, natural active ingredients discovers, develops and produces bioactives, active ingredients of natural origin from its bacterial biodiversity bank, to invent the new generation of sustainable cosmetics and intends to quickly bring its know-how and its products to other fields, such as nutrition and health.

Deinove (XPAR:ALDEI) Headlines

No Headlines